Teyi Pharmaceutical GroupLtd Balance Sheet Health
Financial Health criteria checks 6/6
Teyi Pharmaceutical GroupLtd has a total shareholder equity of CN¥2.0B and total debt of CN¥296.0M, which brings its debt-to-equity ratio to 14.7%. Its total assets and total liabilities are CN¥2.5B and CN¥448.9M respectively. Teyi Pharmaceutical GroupLtd's EBIT is CN¥186.4M making its interest coverage ratio 2818.6. It has cash and short-term investments of CN¥585.6M.
Key information
14.7%
Debt to equity ratio
CN¥296.00m
Debt
Interest coverage ratio | 2818.6x |
Cash | CN¥585.60m |
Equity | CN¥2.02b |
Total liabilities | CN¥448.94m |
Total assets | CN¥2.47b |
Recent financial health updates
Recent updates
We Think Teyi Pharmaceutical GroupLtd (SZSE:002728) Can Stay On Top Of Its Debt
Jun 06Why Teyi Pharmaceutical GroupLtd's (SZSE:002728) Shaky Earnings Are Just The Beginning Of Its Problems
Apr 26Teyi Pharmaceutical Group Co.,Ltd's (SZSE:002728) Shares Bounce 29% But Its Business Still Trails The Market
Mar 06Here's Why We Think Teyi Pharmaceutical GroupLtd (SZSE:002728) Is Well Worth Watching
Feb 27Financial Position Analysis
Short Term Liabilities: 002728's short term assets (CN¥1.1B) exceed its short term liabilities (CN¥413.6M).
Long Term Liabilities: 002728's short term assets (CN¥1.1B) exceed its long term liabilities (CN¥35.4M).
Debt to Equity History and Analysis
Debt Level: 002728 has more cash than its total debt.
Reducing Debt: 002728's debt to equity ratio has reduced from 100.6% to 14.7% over the past 5 years.
Debt Coverage: 002728's debt is well covered by operating cash flow (44.7%).
Interest Coverage: 002728's interest payments on its debt are well covered by EBIT (2818.6x coverage).